-2%
Therapeutic Class: Dual GIP and GLP-1 Receptor Agonist
Dosage Form: Prefilled Syringe for Subcutaneous Injection
Strengths Available: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg
Tirza is indicated as an adjunct to diet and exercise to enhance glycemic control in adults with type 2 diabetes mellitus.
Limitations of Use
Not studied in individuals with a history of pancreatitis.
Not approved for type 1 diabetes mellitus.
⚠️ Always take under the supervision of a registered physician.
